title: Etanercept-induced hypertriglyceridemia during the treatment of recurrent aphthous stomatitis.
authors.forename: Marcos A
authors.initials: MA
authors.lastname: Gonzalez-Lopez
authors.forename: Ricardo
authors.initials: R
authors.lastname: Blanco
authors.forename: Carmen
authors.initials: C
authors.lastname: Garcia-Ibarbia
authors.forename: Carmen M
authors.initials: CM
authors.lastname: Gonzalez-Vela
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Gonzalez-Gay
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000068800:Etanercept; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D007074:Immunoglobulin G / Q000009:adverse effects*; D008297:Male; D018124:Receptors, Tumor Necrosis Factor; D012008:Recurrence; D013281:Stomatitis, Aphthous / Q000188:drug therapy*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept